News & events
Press Releases
On the 28th March 2022, OncoArendi changed its name to Molecure
OncoArendi Therapeutics to Begin the Phase 1 Clinical Evaluation of its Novel Class of Medicines
9 October 2017
OncoArendi Therapeutics announced today that it has filed a Clinical Trial Application (CTA)
7 July 2017
OncoArendi Therapeutics Announces Selection of Its Second Clinical Development Candidate: OATD-02 For the Treatment of Multiple Cancers
21 June 2017
OncoArendi raises 4.5 mln USD (18 million PLN) in an extension of Series A financing round
8 March 2017
OncoArendi receives the President’s Economic Award as the best Polish R&D Company in 2016
17 November 2016
Events & Presentations
Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches – February 19-23, 2020 | Victoria, BC, Canada
27 February 2020
ACS National Meeting & Expo – August 25 – 29, 2019 | San Diego, CA
4 September 2019
EFMC – YMCS – Young Medicinal Chemist Symposium – Ljubljana 02-06.09.2018
17 September 2018